MeiraGTx Holdings (MGTX) Operating Expenses (2017 - 2025)
MeiraGTx Holdings (MGTX) reported Operating Expenses of $48.9 million for Q4 2025, down 7.54% on a YoY basis from $52.9 million in Q4 2024, and up 5.23% quarter-over-quarter from $46.5 million in Q3 2025.
MeiraGTx Holdings (MGTX) Operating Expenses (2017 - 2025) Analysis & Trends
MeiraGTx Holdings has reported Operating Expenses for 9 years, with the latest figure at $48.9 million in Q4 2025.
- For the quarter ending Q4 2025, Operating Expenses fell 7.54% year-over-year to $48.9 million; the trailing twelve-month figure through Dec 2025 stood at $187.4 million (down 5.13% YoY), and the FY2025 full-year result was $187.4 million, down 5.13% from the prior year.
- Operating Expenses for Q4 2025 stood at $48.9 million, up from $46.5 million in the prior quarter.
- The five-year high for Operating Expenses was $52.9 million in Q4 2024, with the low at $25.6 million in Q2 2021.
- Historically, Operating Expenses has averaged $38.9 million across 5 years, with a median of $36.8 million in 2022.
- Annual changes were most pronounced in 2021 — Operating Expenses soared 118.16% — and 2025, when it slipped 8.81%.
- MeiraGTx Holdings' Operating Expenses stood at $28.7 million in 2021, then rose by 24.48% to $35.8 million in 2022, then rose by 28.03% to $45.8 million in 2023, then increased by 15.47% to $52.9 million in 2024, then fell by 7.54% to $48.9 million in 2025.
- The last three Operating Expenses figures came in at $48.9 million (Q4 2025), $46.5 million (Q3 2025), and $48.5 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.33 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -138.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 574,669.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.85 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -67.40 Mn |
| 10 | MeiraGTx Holdings | 910.47 Mn | 844.54 Mn | 74.89 Mn | 48.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 48.89 Mn |
| Sep 30, 2025 | 46.46 Mn |
| Jun 30, 2025 | 48.48 Mn |
| Mar 31, 2025 | 43.52 Mn |
| Dec 31, 2024 | 52.88 Mn |
| Sep 30, 2024 | 50.95 Mn |
| Jun 30, 2024 | 46.19 Mn |
| Mar 31, 2024 | 47.47 Mn |
| Dec 31, 2023 | 45.79 Mn |
| Sep 30, 2023 | 37.87 Mn |
| Jun 30, 2023 | 32.33 Mn |
| Mar 31, 2023 | 35.09 Mn |
| Dec 31, 2022 | 35.77 Mn |
| Sep 30, 2022 | 27.62 Mn |
| Jun 30, 2022 | 34.52 Mn |
| Mar 31, 2022 | 34.37 Mn |
| Dec 31, 2021 | 28.73 Mn |
| Sep 30, 2021 | 29.50 Mn |
| Jun 30, 2021 | 25.60 Mn |
| Mar 31, 2021 | 26.63 Mn |